The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 9, 2026 | Plassche Douglas | EVP Operations | Option exercise(M) | 2.5M | $0.03 | $75K |
| Jan 9, 2026 | Plassche Douglas | EVP Operations | Option exercise(M) | 2.5M | — | $0 |
| Oct 2, 2025 | Plassche Douglas | EVP Operations | Sell(S) | 800K | $0.62 | $496K |
| Aug 25, 2025 | Elite Pharmaceuticals Inc | EVP Operations | Option exercise(M) | 2.5M | $0.03 | $75K |
| Aug 25, 2025 | Elite Pharmaceuticals Inc | EVP Operations | Option exercise(M) | 2.5M | — | $0 |
| Aug 22, 2025 | Elite Pharmaceuticals Inc | EVP Operations | Sell(S) | 500K | $0.52 | $260K |
| Jul 10, 2025 | Kirkov Kirko | Chief Commercial Officer | Buy(P) | 16K | $0.59 | $10K |
| Jul 8, 2025 | Plassche Douglas | EVP Operations | Sell(S) | 200K | $0.58 | $116K |
| Jul 3, 2025 | Plassche Douglas | EVP Operations | Option exercise(M) | 2.5M | $0.03 | $75K |
| Jul 3, 2025 | Plassche Douglas | EVP Operations | Option exercise(M) | 2.5M | — | $0 |
| Oct 24, 2024 | Plassche Douglas | SVP of Operations | Sell(S) | 334K | $0.51 | $170K |
| Oct 23, 2024 | Plassche Douglas | SVP of Operations | Sell(S) | 800K | $0.49 | $392K |
| Mar 29, 2024 | Hakim Nasrat A | CEO, President, Director, 10% Owner | Grant(A) | 49.5M | — | $0 |
| Dec 29, 2023 | Hakim Nasrat A | CEO, President, Director, 10% Owner | Grant(A) | 2.2M | $0.07 | $156K |
| Nov 22, 2023 | Whitnell Jeffrey A | Director | Grant(A) | 548K | $0.04 | $22K |
| Nov 22, 2023 | Caskey Davis S | Director | Grant(A) | 548K | $0.04 | $22K |
| Nov 22, 2023 | Dash Barry H | Director | Grant(A) | 548K | $0.04 | $22K |
| Jan 3, 2023 | Plassche Douglas | Executive VP Operations | Grant(A) | 7.5M | $0.03 | $225K |
| Sep 6, 2022 | Kirkov Kirko | Chief Commercial Officer | Grant(A) | 3.0M | $0.04 | $120K |
| Aug 28, 2022 | Whitnell Jeffrey A | Director | Grant(A) | 460K | $0.04 | $18K |
| Aug 28, 2022 | Caskey Davis S | Director | Grant(A) | 460K | $0.04 | $18K |
| Aug 28, 2022 | Dash Barry H | Director | Grant(A) | 460K | $0.04 | $18K |
| May 16, 2022 | Chen Robert C J | CFO, Secretary, Treasurer | Grant(A) | 900K | $0.04 | $36K |
| Jun 30, 2021 | Whitnell Jeffrey A | Director | Grant(A) | 296K | $0.07 | $21K |
| Jun 30, 2021 | Caskey Davis S | Director | Grant(A) | 296K | $0.07 | $21K |
| Jun 30, 2021 | Dash Barry H | Director | Grant(A) | 296K | $0.07 | $21K |
| May 17, 2021 | Bregman Marc | CFO, Secretary, Treasurer | Grant(A) | 300K | $0.06 | $18K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).